AT363177B - Verfahren zur herstellung einer stabilen thymosinfraktion 5 - Google Patents

Verfahren zur herstellung einer stabilen thymosinfraktion 5

Info

Publication number
AT363177B
AT363177B AT0124578A AT124578A AT363177B AT 363177 B AT363177 B AT 363177B AT 0124578 A AT0124578 A AT 0124578A AT 124578 A AT124578 A AT 124578A AT 363177 B AT363177 B AT 363177B
Authority
AT
Austria
Prior art keywords
thymosine
faction
stable
producing
thymosine faction
Prior art date
Application number
AT0124578A
Other languages
English (en)
Other versions
ATA124578A (de
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ATA124578A publication Critical patent/ATA124578A/de
Application granted granted Critical
Publication of AT363177B publication Critical patent/AT363177B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2292Thymosin; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT0124578A 1977-02-22 1978-02-21 Verfahren zur herstellung einer stabilen thymosinfraktion 5 AT363177B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/770,480 US4082737A (en) 1977-02-22 1977-02-22 Stabilized thymosin composition and method

Publications (2)

Publication Number Publication Date
ATA124578A ATA124578A (de) 1980-12-15
AT363177B true AT363177B (de) 1981-07-10

Family

ID=25088687

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0124578A AT363177B (de) 1977-02-22 1978-02-21 Verfahren zur herstellung einer stabilen thymosinfraktion 5

Country Status (20)

Country Link
US (1) US4082737A (de)
JP (1) JPS53104719A (de)
AT (1) AT363177B (de)
AU (1) AU516946B2 (de)
BE (1) BE864139A (de)
CA (1) CA1099633A (de)
CH (1) CH632164A5 (de)
DE (1) DE2807202C2 (de)
DK (1) DK78378A (de)
FR (1) FR2380782A1 (de)
GB (1) GB1546027A (de)
IE (1) IE46409B1 (de)
IL (1) IL54063A0 (de)
IT (1) IT1092337B (de)
LU (1) LU79090A1 (de)
NL (1) NL189281C (de)
NZ (1) NZ186489A (de)
PH (1) PH13858A (de)
SE (1) SE444647B (de)
ZA (1) ZA78890B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3633651A1 (de) * 1986-10-03 1988-04-14 Alfred Dr Dick Verwendung von fraktionen aus thymus- und milzextrakten zur behandlung der psoriasis

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732587A1 (de) * 1976-09-22 1978-03-23 Bach Jean Francois Polypeptid mit thymischer wirksamkeit
US4148788A (en) * 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1
US4239498A (en) * 1978-11-27 1980-12-16 Rule Allyn H Method of preparing thymic factors and composition
US4264571A (en) * 1979-01-22 1981-04-28 George Washington University Radioimmunoassay of thymosin α1
EP0057702A1 (de) * 1980-08-08 1982-08-18 Rak-A-Van Pty Limited Verbessertes regal
US4389343A (en) * 1981-12-24 1983-06-21 Hoffmann-La Roche Inc. Immunopotentiating peptides from thymus
US4388234A (en) * 1981-12-28 1983-06-14 Hoffmann-La Roche Inc. Peptide isolation
US4614731A (en) * 1983-09-15 1986-09-30 Hoffmann-La Roche Inc. Peptide having immunopotentiating activity similar to thymosin alpha1
US4659694A (en) * 1983-10-27 1987-04-21 Hoffmann-La Roche Inc. Prothymosin alpha
US4814434A (en) * 1984-02-03 1989-03-21 Ventres Laboratories, Inc. Inducer of T-suppressor cells
US5273963A (en) * 1991-03-29 1993-12-28 The George Washington University Compositions and methods for treating small cell and nonsmall cell lung cancers
JP4404866B2 (ja) 2006-03-03 2010-01-27 ゼライス株式会社 エンドトキシン含有量を低減したゼラチンの製造方法および低エンドトキシンゼラチン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002602A (en) * 1974-03-11 1977-01-11 Gideon Goldstein Ubiquitous immunopoietic polypeptide (UBIP) and methods
US4010148A (en) * 1975-05-12 1977-03-01 Board Of Regents Of The University Of Texas System Purified thymosin and process
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3633651A1 (de) * 1986-10-03 1988-04-14 Alfred Dr Dick Verwendung von fraktionen aus thymus- und milzextrakten zur behandlung der psoriasis

Also Published As

Publication number Publication date
US4082737A (en) 1978-04-04
IE780335L (en) 1978-08-22
NZ186489A (en) 1981-01-23
IT1092337B (it) 1985-07-06
ZA78890B (en) 1979-01-31
AU516946B2 (en) 1981-07-02
JPS618806B2 (de) 1986-03-18
GB1546027A (en) 1979-05-16
BE864139A (fr) 1978-08-21
IT7819791A0 (it) 1978-01-30
ATA124578A (de) 1980-12-15
SE7802014L (sv) 1978-08-23
PH13858A (en) 1980-10-22
DE2807202C2 (de) 1987-04-02
NL189281C (nl) 1993-03-01
AU3334378A (en) 1979-08-23
NL7801422A (nl) 1978-08-24
IL54063A0 (en) 1978-04-30
LU79090A1 (fr) 1979-05-25
NL189281B (nl) 1992-10-01
DK78378A (da) 1978-08-23
DE2807202A1 (de) 1978-08-24
FR2380782B1 (de) 1980-01-18
SE444647B (sv) 1986-04-28
IE46409B1 (en) 1983-06-01
FR2380782A1 (fr) 1978-09-15
JPS53104719A (en) 1978-09-12
CH632164A5 (de) 1982-09-30
CA1099633A (en) 1981-04-21

Similar Documents

Publication Publication Date Title
AT360148B (de) Verfahren zur herstellung einer stabilen injektionsloesung
AT370592B (de) Verfahren zur herstellung einer kaugummimasse
ATA932977A (de) Verfahren zur herstellung einer materialbahn
AT378018B (de) Verfahren zur herstellung einer schichtstoffkombination
AT357248B (de) Verfahren zur herstellung einer selektivbe- schichtung
ATA55880A (de) Verfahren zur herstellung einer katalysatorzusammensetzung
AT363177B (de) Verfahren zur herstellung einer stabilen thymosinfraktion 5
AT358015B (de) Verfahren zur herstellung einer 2-arylpropion- saeure
ATA151278A (de) Verfahren zur herstellung einer tontaube
AT357570B (de) Verfahren zur herstellung einer hydroxyver- bindung
ATA499079A (de) Verfahren zur herstellung eines synthetischen crepegarns
DD148468A3 (de) Verfahren zur herstellung einer bohrspuelung
AT368390B (de) Verfahren zur herstellung einer heterovakzine
ATA449178A (de) Verfahren zur herstellung eines keramischen gegenstandes
AT361633B (de) Verfahren zur herstellung einer festen steroidzusammensetzung
AT347579B (de) Verfahren zur herstellung einer stabilen injizierbaren loesung
DD138506A1 (de) Verfahren zur herstellung einer waessrigen loesung
DD130910A1 (de) Verfahren zur herstellung einer suessware
AT364848B (de) Verfahren zur herstellung einer b-beta-acylaminopenicillansaure
DD136196A1 (de) Verfahren zur herstellung einer blockwicklung
AT363588B (de) Verfahren zur herstellung einer stabilen sauren sekretinzubereitung
DD132677A2 (de) Verfahren zur herstellung einer folienfadenschar
DD131145A1 (de) Verfahren zur herstellung einer metall-keramik-verbindung
DD126089A5 (de) Verfahren zur herstellung einer trockendessert-mischung
ATA280480A (de) Verfahren zur herstellung einer semitrichinoyl enthaltenden loesung

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee